XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities    
Net income $ 151,036 $ 175,207
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 11,542 9,488
Deferred income taxes (5,510) (12,623)
Stock-based compensation expense 15,571 13,030
Provision for doubtful accounts 2,984 749
Provision for excess and obsolete inventory 4,120 3,912
Accretion of discounts and premiums on marketable securities (10,167) (8,463)
Unrealized currency (gain) loss on foreign denominated transactions (3,100) 7,487
Mark-to-market adjustment on foreign exchange contracts 583  
Changes in operating assets and liabilities:    
Accounts receivable 28,774 (26,674)
Inventories 11,299 (79,494)
Prepaid expenses and other current assets (8,110) (16,493)
Accounts payable and other current liabilities (2,738) (8,916)
Deferred revenue (46,700) 47,704
Income taxes (14,132) (3,672)
Other assets and liabilities (7,414) (9,948)
Net cash provided by operating activities 128,038 91,294
Cash flows from investing activities    
Expenditures for property, plant and equipment and capitalized software (7,523) (10,503)
Purchase of short-term investments (433,894) (271,583)
Maturities of short-term investments 323,570 207,907
Net cash used in investing activities (117,847) (74,179)
Cash flows from financing activities    
Net settlement on restricted stock grants (11,408) (15,814)
Repurchase of common stock (45,358) (37,498)
Proceeds from Employee Stock Purchase Plan purchases 1,242 957
Principal payments on finance lease obligation (1,125) (915)
Proceeds from exercise of stock options   25
Net cash used in financing activities (56,649) (53,245)
Effect of exchange rate changes on cash and cash equivalents (774) (1,267)
Net decrease in cash, cash equivalents and restricted cash (47,232) (37,397)
Cash, cash equivalents and restricted cash at beginning of period 173,951 186,347
Cash, cash equivalents and restricted cash at end of period $ 126,719 $ 148,950